nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Addition of trastuzumab to perioperative chemotherapy in HER2-positive gastroesophageal adenocarcinoma patients: A multicenter retrospective observational AGEO study
|
Frydman, Anne-Esther |
|
|
56 |
1 |
p. 198-205 |
artikel |
2 |
A gastroesophageal junction polyp with malignant biopsy result
|
Bao, Wenwen |
|
|
56 |
1 |
p. 206-208 |
artikel |
3 |
Anti-IL23 in inflammatory bowel disease patients with dermatological indication: The shared gastroenterological-dermatological clinic experience
|
Ribaldone, Davide Giuseppe |
|
|
56 |
1 |
p. 220-222 |
artikel |
4 |
Aquaporin 1 in cancer: Oncogene or a tumor suppressor?
|
Guo, Hong-Mei |
|
|
56 |
1 |
p. 218 |
artikel |
5 |
Author's Reply: “Aquaporin 1 in cancer: Oncogene or a tumor suppressor?”
|
Zhuang, Meng-Qi |
|
|
56 |
1 |
p. 219 |
artikel |
6 |
Author's Reply: “A retrospective analysis of treatment patterns, drug discontinuation and healthcare costs in Crohn's disease patients treated with biologics”
|
Degli Esposti, Luca |
|
|
56 |
1 |
p. 216-217 |
artikel |
7 |
Cannulation rates and technical performance evaluation of commericially available single-use duodenoscopes for endoscopic retrograde cholangiopancreatography: A systematic review and meta-analysis
|
Ramai, Daryl |
|
|
56 |
1 |
p. 123-129 |
artikel |
8 |
Clinical efficacy and nocebo effect following non-medical biosimilar switch in patients with inflammatory bowel disease: A prospective observational study
|
Wetwittayakhlang, Panu |
|
|
56 |
1 |
p. 35-42 |
artikel |
9 |
Comparison of the severity of metabolic, liver and cardiovascular damage in NAFLD patients attending the hepatology clinic over the last three decades
|
Lombardi, Rosa |
|
|
56 |
1 |
p. 144-151 |
artikel |
10 |
Diagnostic value of anti-integrin αvβ6 antibodies in ulcerative colitis
|
Marafini, Irene |
|
|
56 |
1 |
p. 55-60 |
artikel |
11 |
Disease course of ulcerative proctitis in children: A population-based study on behalf of the SIGENP IBD Group
|
Martinelli, Massimo |
|
|
56 |
1 |
p. 70-76 |
artikel |
12 |
Endoscopic submucosal dissection for oesophageal cavernous haemangioma accompanied by squamous epithelial dysplasia
|
Wu, Chen |
|
|
56 |
1 |
p. 211-213 |
artikel |
13 |
Endoscopic ultrasound-guided drainage of pancreatic collections with dedicated metal stents: A nationwide, multicenter, propensity score-matched comparison
|
Coluccio, Chiara |
|
|
56 |
1 |
p. 159-169 |
artikel |
14 |
Estimation of patients affected by inflammatory bowel disease potentially eligible for biological treatment in a real-world setting
|
Degli Esposti, Luca |
|
|
56 |
1 |
p. 29-34 |
artikel |
15 |
EUS guided fine needle biopsy in the diagnosis of pancreatic Castleman disease (with video)
|
Shi, Haitao |
|
|
56 |
1 |
p. 209-210 |
artikel |
16 |
Full Title Page /Editorial Board
|
|
|
|
56 |
1 |
p. i-ii |
artikel |
17 |
Golimumab improves health-related quality of life of patients with moderate-to-severe ulcerative colitis: Results of the go-care study
|
Saibeni, S. |
|
|
56 |
1 |
p. 83-91 |
artikel |
18 |
Histological healing as a predictor of sustained clinical remission in paediatric ulcerative colitis
|
Scarallo, Luca |
|
|
56 |
1 |
p. 43-49 |
artikel |
19 |
Histologic findings at diagnosis as predictive markers of clinical outcome in pediatric ulcerative colitis
|
Catassi, Giulia |
|
|
56 |
1 |
p. 106-111 |
artikel |
20 |
Impacts of gut microbiota alteration on age-related chronic liver diseases
|
Adhikary, Subhamay |
|
|
56 |
1 |
p. 112-122 |
artikel |
21 |
Importance of age, complications, progression, and risk factors in Crohn's Disease management with biologics
|
Masood, Nimra |
|
|
56 |
1 |
p. 214-215 |
artikel |
22 |
Living donor liver transplant in acute on chronic liver failure grade 3: Who not to transplant
|
Singh, Shweta A. |
|
|
56 |
1 |
p. 152-158 |
artikel |
23 |
Long-term effectiveness and safety of anti-TNF in pediatric-onset inflammatory bowel diseases: A population-based study
|
Fumery, Mathurin |
|
|
56 |
1 |
p. 21-28 |
artikel |
24 |
Maintenance of clinical remission with biologics and small molecules in inflammatory bowel disease according to trial design: Meta-analysis
|
Barberio, Brigida |
|
|
56 |
1 |
p. 7-14 |
artikel |
25 |
Mendelian randomization analysis reveals causality of inflammatory bowel disease on risks of Henoch-Schönlein purpura and immune thrombocytopenia
|
Li, Haojia |
|
|
56 |
1 |
p. 92-97 |
artikel |
26 |
Modifiable lifestyle factors, genetic and acquired risk, and the risk of severe liver disease in the UK Biobank cohort
|
Liu, Zhening |
|
|
56 |
1 |
p. 130-136 |
artikel |
27 |
Outcomes of minor versus major papilla rendez-vous for EUS-guided pancreatic duct drainage
|
Bronswijk, Michiel |
|
|
56 |
1 |
p. 170-175 |
artikel |
28 |
Real-world effectiveness and safety of ustekinumab in bio-naive patients with moderate-to-severe Crohn's disease: A Canadian multi-center study
|
Bessissow, Talat |
|
|
56 |
1 |
p. 61-69 |
artikel |
29 |
Safety and effectiveness of tofacitinib in ulcerative colitis: Data from TOFA-UC, a SN-IBD study
|
Macaluso, Fabio Salvatore |
|
|
56 |
1 |
p. 15-20 |
artikel |
30 |
Switching from VEDOlizumab intravenous to subcutaneous formulation in ulcerative colitis patients in clinical remission: The SVEDO Study, an IG-IBD study
|
Ribaldone, Davide Giuseppe |
|
|
56 |
1 |
p. 77-82 |
artikel |
31 |
Telemedicine in inflammatory bowel disease from its origin to the post pandemic golden age: A narrative review
|
Fantini, Massimo Claudio |
|
|
56 |
1 |
p. 1-6 |
artikel |
32 |
Timing of proper introduction, optimization and maintenance of anti-TNF therapy in IBD: Results from a Delphi consensus
|
Ardizzone, Sandro |
|
|
56 |
1 |
p. 98-105 |
artikel |
33 |
Tracking incidentally discovered pancreatic cysts smaller than 30 mm: Natural course and predictors of malignancy
|
Kim, Hyo Suk |
|
|
56 |
1 |
p. 137-143 |
artikel |
34 |
Tumor suppressor CLCA1 inhibits angiogenesis via TGFB1/SMAD/VEGF cascade and sensitizes hepatocellular carcinoma cells to Sorafenib
|
He, Jin |
|
|
56 |
1 |
p. 176-186 |
artikel |
35 |
Understanding endoscopic and clinicopathological features of patients with very early onset inflammatory bowel disease: Results from a decade of study
|
Ye, Ziqing |
|
|
56 |
1 |
p. 50-54 |
artikel |
36 |
VEPH1 suppresses the progression of gastric cancer by regulating the Hippo-YAP signalling pathway
|
Nie, Xubiao |
|
|
56 |
1 |
p. 187-197 |
artikel |